VNRX – volitionrx limited (US:NASDAQ)
Stock Stats
News
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $3.00 price target on the stock.
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test
Form 4 VOLITIONRX LTD For: Feb 01 Filed by: Plummer Nicholas
Form 4 VOLITIONRX LTD For: Feb 01 Filed by: Rootsaert Rodney Gerard
Form 4 VOLITIONRX LTD For: Feb 01 Filed by: Forterre Gael
Form D/A VOLITIONRX LTD
Form PRE 14A VOLITIONRX LTD For: Jan 22
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.